Press Room http://www.news.sanofi.us/ MediaRoom Toujeo® reduced risk of severe low blood sugar compared to insulin glargine 100 Units/mL and insulin detemir http://www.news.sanofi.us/2018-02-01-Toujeo-R-reduced-risk-of-severe-low-blood-sugar-compared-to-insulin-glargine-100-Units-mL-and-insulin-detemir Wed, 14 Feb 2018 07:20:00 -0500 http://www.news.sanofi.us/2018-02-01-Toujeo-R-reduced-risk-of-severe-low-blood-sugar-compared-to-insulin-glargine-100-Units-mL-and-insulin-detemir Sanofi Delivers 2017 Business EPS in line with Guidance http://www.news.sanofi.us/2018-02-07-Sanofi-Delivers-2017-Business-EPS-in-line-with-Guidance Wed, 07 Feb 2018 07:38:00 -0500 http://www.news.sanofi.us/2018-02-07-Sanofi-Delivers-2017-Business-EPS-in-line-with-Guidance Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs http://www.news.sanofi.us/Sanofi-and-Regeneron-to-accelerate-and-expand-investment-for-cemiplimab-and-dupilumab-development-programs Companies also announce submission of dupilumab supplemental BLA for uncontrolled, persistent asthma Mon, 08 Jan 2018 18:05:00 -0500 http://www.news.sanofi.us/Sanofi-and-Regeneron-to-accelerate-and-expand-investment-for-cemiplimab-and-dupilumab-development-programs Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma http://www.news.sanofi.us/Sanofi-and-Regeneron-announce-positive-topline-pivotal-results-for-PD-1-antibody-cemiplimab-in-advanced-cutaneous-squamous-cell-carcinoma High and durable response rate in disease without any FDA-approved therapies Wed, 13 Dec 2017 12:27:00 -0500 http://www.news.sanofi.us/Sanofi-and-Regeneron-announce-positive-topline-pivotal-results-for-PD-1-antibody-cemiplimab-in-advanced-cutaneous-squamous-cell-carcinoma FDA Approves Sanofi's Admelog® (insulin lispro injection) http://www.news.sanofi.us/2017-12-11-FDA-Approves-Sanofis-Admelog-R-insulin-lispro-injection * First FDA-approved follow-on mealtime insulin Mon, 11 Dec 2017 14:40:00 -0500 http://www.news.sanofi.us/2017-12-11-FDA-Approves-Sanofis-Admelog-R-insulin-lispro-injection